CV Therapeutics Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/08 FY 2008 – amended

ended 12/31/08 FY 2008

ended 09/30/08 Q3

ended 06/30/08 Q2

ended 03/31/08 Q1

Prospectuses and Registrations Filter

Issuer tender offer – amended

Issuer tender offer

Removal from listing

Securities registration termination

Tender offer solicitation – amended

Ownership Filter

Suvari Tricia Borga

Blackburn Brent K

Spiegelman Daniel K

News Filter

Material Definitive Agreement, Material Modification to Rights of Security Holders, Other Events, Financial Statements or Exhibits

Reports Phase 1 Data Showing PROOF OF CONCEPT FOR Cvt-3619, a NOVEL POTENTIAL TREATMENT FOR CARDIOMETABOLIC DISEASES

Ranexa® Now Available in United Kingdom and Germany

Advises Stockholders to Take No Action at This Time in Response to Astellas’ Tender Offer

Therapeutics’ Board of Directors Rejects Astellas Unsolicited Proposal

Proxies Filter

Proxy materials by non-management

Proxy materials by non-management

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Other Filter

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order

Confidential treatment order